• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Sepsis
Tag:

Sepsis

News

Kyle Busch Dies Following Battle with Sepsis, Family Confirms

by Rachel Morgan News Editor May 23, 2026
written by Rachel Morgan News Editor

Two-time NASCAR champion Kyle Busch has died at the age of 41. According to a statement from his family, the driver passed away on Thursday following a medical emergency caused by severe pneumonia that progressed into sepsis.

The situation began to unfold on Wednesday in Concord, North Carolina, while Busch was testing in a Chevrolet racing simulator. He became unresponsive and was transported to a hospital in Charlotte. Emergency dispatch records indicate that responders were alerted to an individual experiencing shortness of breath, high fever, and the coughing up of blood.

Dakota Hunter, vice president of Kyle Busch Companies, confirmed that the family received the medical evaluation regarding the cause of death on Saturday. Sepsis, identified by the Centers for Disease Control and Prevention as a life-threatening emergency, occurs when the body’s immune system has an extreme, overactive response to an infection, leading to widespread inflammation and potential organ damage.

Did You Know? Throughout his two-decade career, Kyle Busch secured 234 race wins across NASCAR’s top three series, a total that stands as the most of any driver in the history of the sport.

The Pressure to Perform

In the days leading up to his death, Busch had continued to compete despite showing signs of illness. He had previously radioed his team during a race at Watkins Glen on May 10, mentioning a need for a medical “shot” for what was believed to be a sinus cold. Following that race, he managed to win the Truck Series event at Dover and placed 17th in the All-Star race.

The Pressure to Perform
Kyle Busch Dies Following Battle Charlotte Motor Speedway

Reflecting on the demands placed on professional drivers, fellow competitor Brad Keselowski noted the intense pressure to avoid missing races. Keselowski explained that drivers often fear being replaced if they admit to feeling unwell, leading many to attempt to “power through” health issues rather than stepping away from the driver’s seat.

Expert Insight: The loss of a competitor like Busch highlights the delicate balance between athletic resilience and physical vulnerability. While the drive to compete is a hallmark of professional racing, the incident underscores the significant risks involved when high-intensity physical demands intersect with underlying health complications.

Looking Ahead

As the racing community processes this loss, the immediate focus remains on honoring Busch’s legacy. During Sunday’s Coca-Cola 600 at Charlotte Motor Speedway, all 39 drivers in the field are set to participate with a black No. 8 decal on their vehicles as a tribute.

Details emerge on sudden illness that led to Kyle Busch's shocking death

It is likely that this event will trigger broader discussions within the racing industry regarding driver health protocols. Future safety measures could involve more stringent medical monitoring or updated policies on when drivers are required to sit out of competition, as teams and organizations evaluate how to better support the physical well-being of those behind the wheel.

Frequently Asked Questions

What was the medical cause of Kyle Busch’s death?
According to a family statement, Busch died after severe pneumonia progressed into sepsis, causing rapid and overwhelming complications.

Frequently Asked Questions
Kyle Busch Dies Following Battle Brad Keselowski

Was there any indication that Busch was ill before his hospitalization?
Yes. He had radioed his team during a race on May 10 regarding a sinus cold and a need for a doctor’s assistance. Brad Keselowski also confirmed that he was aware Busch had not been feeling well recently.

How is the racing community honoring Busch?
All 39 drivers scheduled for the Coca-Cola 600 at Charlotte Motor Speedway will carry a black No. 8 decal on their cars to honor him.

How might this tragedy change the approach to driver health and fitness in professional racing?

May 23, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Cranberry juice may help stop antibiotic resistance in UTIs

by Chief Editor May 7, 2026
written by Chief Editor

The End of the ‘Superbug’ Era? How Nature is Recharging Our Antibiotics

For decades, the medical community has been locked in an arms race with bacteria. As we develop stronger antibiotics, pathogens like uropathogenic Escherichia coli (UPEC) evolve faster, finding clever ways to block drugs from entering their cells. This is the heart of antimicrobial resistance (AMR), a crisis that makes common infections potentially lethal.

The End of the 'Superbug' Era? How Nature is Recharging Our Antibiotics
Cranberry Bacteria

However, a paradigm shift is occurring. Instead of searching for entirely new “miracle drugs”—a process that is slow and prohibitively expensive—researchers are looking at antibiotic adjuvants. These are compounds that don’t kill bacteria themselves but “unlock the door,” allowing existing antibiotics to work more effectively.

Did you know? More than 400 million people suffer from urinary tract infections (UTIs) every year. For many, the first line of defense is an antibiotic called fosfomycin, but the rise of resistant strains is making this gold-standard treatment less reliable.

Reprogramming the Enemy: The Cranberry Breakthrough

Recent findings published in Applied and Environmental Microbiology have revealed a fascinating interaction between cranberry juice, and fosfomycin. It turns out that cranberry juice doesn’t just “help” the antibiotic; it actually reprograms how the bacteria behave.

Bacteria usually absorb fosfomycin through a specific transport system called GlpT. When bacteria become resistant, they often mutate this “doorway” so the drug can’t get in. The breakthrough? Cranberry juice suppresses the GlpT system but keeps another doorway—the UhpT system—wide open.

By shifting the entry point, cranberry juice effectively bypasses the bacteria’s defenses. In lab settings, this combination significantly boosted the activity of fosfomycin and, more importantly, suppressed the emergence of new mutations. In some cases, the rate of spontaneous resistance dropped by five orders of magnitude.

The Shift Toward ‘Combination Therapeutics’

This discovery signals a broader trend in pharmacology: the move toward combination therapeutics. Rather than a single-bullet approach, the future of medicine likely involves a “cocktail” of a pharmaceutical agent and a natural potentiator.

The Shift Toward 'Combination Therapeutics'
Bacteria

Imagine a future where a prescription isn’t just a pill, but a targeted kit containing a standardized extract of cranberry compounds designed to sensitize the bacteria before the antibiotic is administered. This would not only clear infections faster but could potentially lower the required dose of antibiotics, reducing side effects for the patient.

Pro Tip: While lab results are promising, always consult a healthcare provider before using cranberry juice as a medical treatment. The concentration of active compounds in store-bought juices varies wildly, and medical-grade extracts are often necessary for therapeutic effects.

Future Trends: Beyond the Cranberry

The success of this “re-sensitization” strategy opens the door to several exciting frontiers in healthcare and biotechnology:

View this post on Instagram about Future Trends, Precision Adjuvants
From Instagram — related to Future Trends, Precision Adjuvants
  • Precision Adjuvants: We may soon see diagnostic tests that identify exactly which transport system a patient’s specific bacterial strain is using, allowing doctors to prescribe the exact natural adjuvant needed to break through that specific defense.
  • Reviving ‘Dead’ Antibiotics: Many antibiotics were abandoned because bacteria developed resistance. If we find the right natural partners to “re-sensitize” these bugs, we could bring a whole library of old drugs back into the fight.
  • Nutraceutical-Pharmaceutical Hybrids: The line between “supplements” and “medicine” is blurring. We are moving toward a world where “food-based medicine” is scientifically validated and integrated into clinical protocols.

Real-World Impact on Global Health

The implications for global health are massive. AMR is one of the top ten global public health threats facing humanity. By extending the lifespan of existing drugs like fosfomycin, we buy critical time for the development of next-generation therapies.

This approach is particularly vital in developing regions where access to the newest, most expensive antibiotics is limited. Utilizing accessible, natural components to enhance affordable, existing drugs is a sustainable path toward global health equity.

Frequently Asked Questions

Can I just drink cranberry juice to cure a UTI?
Not necessarily. While the study shows cranberry juice boosts antibiotic efficacy in a lab, it doesn’t replace the antibiotic itself. Always follow a doctor’s prescription for active infections.

Study suggests cranberry juice may help antibiotics fight UTIs

What is fosfomycin?
Fosfomycin is a widely used, first-line antibiotic specifically effective against many types of urinary tract infections.

Does this mean antibiotics will stop becoming resistant?
Bacteria will always evolve, but “reprogramming” their uptake pathways gives us a new tool to stay one step ahead of them.

Is this treatment available in pharmacies now?
The current findings are in vitro (lab-based). Clinical trials in humans are the next necessary step before this becomes a standard medical prescription.

Join the Conversation

Do you think natural compounds are the key to solving the antibiotic crisis, or should we focus entirely on synthetic drug development? Let us know your thoughts in the comments below or subscribe to our newsletter for the latest breakthroughs in medical science!

Subscribe for Updates

May 7, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

new national standard for emergency laparotomy

by Chief Editor May 1, 2026
written by Chief Editor

New National Standard Aims to Reduce Risks in Emergency Abdominal Surgery

Australia’s first Emergency Laparotomy Clinical Care Standard launched in May 2026, is set to transform the care pathway for over 15,000 Australians each year facing urgent, life-threatening abdominal conditions. The standard addresses a critical gap in consistent care, aiming to improve outcomes for a patient population facing some of the highest risks in hospital settings.

The Challenge of Emergency Laparotomy

Emergency laparotomy – surgery to address conditions like bowel obstruction, perforation, or severe infection – is a high-risk procedure. Although common, with more than 15,000 performed annually in Australia, it carries a mortality rate of around 7%, potentially rising to 20% for older adults, those with frailty, or those presenting with sepsis. Currently, care varies significantly across the country.

View this post on Instagram about Safety and Quality, Health Care
From Instagram — related to Safety and Quality, Health Care

“When a patient presents with a stroke, the care pathways are clear and consistent nationwide,” explains Conjoint Professor Carolyn Hullick, Chief Medical Officer at the Australian Commission on Safety and Quality in Health Care. “But for emergency laparotomy, there hasn’t been that standardized national approach.”

Key Elements of the New Standard

The new Clinical Care Standard focuses on four key elements to improve patient care:

What is the National Emergency Laparotomy Audit?
  • Rapid assessment and escalation: Establishing systems for quick identification of patients needing urgent surgical review.
  • Identifying high-risk patients: Consistent apply of preoperative risk and frailty assessments to guide care.
  • Risks and goals of care discussions: Supporting clinicians in having open and honest conversations with patients and families about the benefits and risks of surgery, aligning treatment with patient preferences.
  • Involving physicians for older patients: Establishing systems for collaborative management with physicians experienced in the care of older adults.

The standard emphasizes the importance of multidisciplinary perioperative care, timely access to theatre, and consistent documentation of patient goals.

Addressing Systemic Issues

Recent audits, such as the Australian and New Zealand Emergency Laparotomy Audit – Quality Improvement (ANZELA-QI) report, have highlighted areas for improvement. The report revealed that only 20% of patients recommended for surgery within two hours actually reached the operating theatre within that timeframe. Access to consultant surgeons and anaesthetists after hours is also inconsistent, and frailty assessments are not routinely performed.

The standard aims to address these issues by providing clear guidance on establishing systems for rapid assessment, ensuring timely access to specialists, and prioritizing frailty assessment, particularly for older patients.

Lessons from the UK: The NELA Model

The Australian Commission on Safety and Quality in Health Care points to the success of the National Emergency Laparotomy Audit (NELA) in the United Kingdom as a model for improvement. NELA has been credited with reducing mortality rates by over 30% in its first decade through standardized data collection and quality improvement initiatives.

Lessons from the UK: The NELA Model
Safety and Quality Health Care Improvement

Regional Success Story: Bunbury Regional Hospital

Bunbury Regional Hospital in Western Australia demonstrates the potential impact of data-driven quality improvement. By regularly reviewing emergency laparotomy data, the hospital has improved its performance against ANZELA-QI indicators and achieved one of the lowest crude mortality rates in Australia. A key factor in their success has been the consistent use of clinical frailty assessment and mortality risk scores to inform perioperative care pathways.

“Our registrars know they can’t call me at 2 am about doing a laparotomy unless they already have these scores,” says Dr. Jacinta Cover, General Surgeon and Head of Department at Bunbury Regional Hospital. “Regularly going through that data cycle and looking at the improved outcomes overall for the patients has brought everybody on board; it’s a standardized process in our department.”

Future Trends and the Role of Technology

Looking ahead, several trends are likely to shape the future of emergency laparotomy care:

  • Enhanced Predictive Modeling: Artificial intelligence and machine learning algorithms could be used to predict which patients are at highest risk of complications, allowing for more targeted interventions.
  • Telemedicine and Remote Monitoring: Telemedicine could improve access to specialist expertise in rural and remote areas, facilitating faster decision-making and improved care coordination.
  • Personalized Medicine: Advances in genomics and proteomics could lead to personalized treatment strategies tailored to individual patient characteristics.
  • Expanded Use of Minimally Invasive Techniques: Laparoscopic approaches, when appropriate, can reduce surgical trauma and improve recovery times.

FAQ

Q: Who does this standard apply to?
A: The standard applies to patients aged 18 and over undergoing emergency surgery for urgent, high-risk, intra‑abdominal conditions.

Q: What is ANZELA-QI?
A: ANZELA-QI is the Australian and New Zealand Emergency Laparotomy Audit – Quality Improvement, a clinical quality registry.

Q: Is this standard mandatory?
A: Hospitals accredited to the National Safety and Quality Health Service Standards are expected to consider and implement the Clinical Care Standard.

Q: Where can I find more information?
A: Visit the Australian Commission on Safety and Quality in Health Care website: www.safetyandquality.gov.au/el-ccs

Pro Tip: Regularly review and update your hospital’s emergency laparotomy protocols to ensure they align with the latest evidence-based guidelines.

Do you have experience implementing new clinical care standards in your hospital? Share your insights in the comments below!

May 1, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Perth woman warns about pedicure safety after severe infection almost costs her a toe

by Chief Editor April 24, 2026
written by Chief Editor

The Shift Toward Medical-Grade Foot Care: Podiatry vs. Nail Salons

The distinction between aesthetic nail treatments and medical foot care is becoming a critical point of discussion for consumer safety. While nail salons provide cosmetic services, professional podiatry clinics operate under much tighter sterilization regulations.

The Shift Toward Medical-Grade Foot Care: Podiatry vs. Nail Salons
Sepsis Regulations Medical

According to podiatrist Robert Mullins, every instrument in a podiatry clinic should be cleaned, disinfected, sterilized, and packaged to maintain that sterility. These tools should be opened directly in front of the client or disposed of if they are single-use.

For those dealing with cracked skin or requiring specific treatment, the trend is moving toward seeking professional podiatric care rather than salon services to ensure a higher standard of infection control.

Pro Tip: When visiting a nail bar, observe how tools are handled. Be cautious if instruments are kept open in a trolley rather than in individually sterilized, sealed packaging.

Recognizing the Warning Signs of Sepsis

A severe infection can escalate quickly into sepsis, which is the body’s extreme and life-threatening response to an infection, typically caused by bacteria. In some cases, this condition can be fatal in as little as 12 hours if left untreated.

Recognizing the Warning Signs of Sepsis
Kyla Willcox Sepsis Kyla

The experience of Kyla Willcox highlights the rapid onset of symptoms. After a pedicure involving a pumice stone on a callus, she experienced:

  • Pain and bruising at the site of the treatment.
  • The toe becoming red with blackness appearing underneath.
  • Severe systemic reactions, including shaking, feeling freezing cold, excessive sweating, and feeling “unbelievably sick.”

Medical professionals, including clinical microbiologist David New, note that infections can occur when instruments erode or break the skin, allowing bacteria—even those that live naturally on the skin—to enter areas where they do not belong.

Did you know? Sepsis can progress so quickly that medical intervention is required immediately. Kyla Willcox was admitted to the hospital just in time to prevent the amputation of her toe, which would have been necessary had the infection reached the bone.

The Push for Stricter Salon Regulations

There is a growing call for better regulation of nail bars, particularly those located in shopping centers, compared to traditional beauty therapists and salons.

Health Alert: Pedicure safety

In Western Australia, salons that perform skin penetration procedures are regulated by the Health (Skin Penetration Procedure) Regulations 1998. These businesses must register with their local government and undergo periodic inspections by environmental health officers to ensure compliance.

However, the case of the Ellenbrook nail salon has prompted investigations by the City of Swan. This highlights a gap between existing regulations and the actual practice of hygiene in some establishments, where tools may not be individually sterilized.

The Impact of Treatment

Recovery from severe infections can be grueling. In addition to the initial infection, the treatment process itself can carry risks. Kyla Willcox reported experiencing irritated veins and a blood clot resulting from the large doses of antibiotics required to save her toe.

The Impact of Treatment
Kyla Willcox Sepsis Kyla

Frequently Asked Questions

What is sepsis?

Sepsis is a life-threatening condition that occurs when the body has an extreme response to an infection, normally caused by bacteria.

How do nail salon infections happen?

Infections can occur if instruments break or erode the skin, allowing bacteria to enter the body. This risk is increased if tools are not properly disinfected or sterilized.

What is the difference between a nail salon and a podiatry clinic regarding hygiene?

Podiatry clinics generally have tighter regulations where every instrument must be cleaned, disinfected, sterilized, and packaged, then opened in front of the client.

Are nail salons regulated?

Yes, in certain jurisdictions they are regulated by health laws (such as the Health (Skin Penetration Procedure) Regulations 1998) and must be registered and inspected by local government health officers.

We want to hear from you: Have you ever questioned the hygiene standards at your local nail salon? Share your experiences in the comments below or subscribe to our newsletter for more health and safety insights.

April 24, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Machine learning model can predict 28-day mortality in sepsis patients

by Chief Editor March 27, 2026
written by Chief Editor

AI-Powered Precision in Sepsis Care: A Modern Era of Early Risk Prediction

Sepsis, a life-threatening condition arising from the body’s overwhelming response to an infection, remains a major challenge in intensive care units (ICUs). The development of acute respiratory failure (ARF) as a complication significantly increases the risk of death. But, a new machine learning model is offering a beacon of hope, promising more accurate and timely risk assessment for these critically ill patients.

The Challenge of Early Sepsis Prognosis

Despite advancements in critical care, predicting which sepsis patients will succumb to the illness within the first 28 days has been notoriously difficult. Early and accurate assessment is crucial for optimizing treatment strategies and allocating limited ICU resources effectively. Currently, clinicians rely on a combination of clinical judgment and established scoring systems, but these often fall short in providing a precise prognosis.

A New Model for Predicting 28-Day Mortality

Researchers, led by Dr. Jian Liu, have developed and validated a machine learning model specifically designed to predict 28-day mortality in sepsis patients experiencing ARF. The model leverages routinely collected clinical data from the first 24 hours of ICU admission. This focus on readily available information is a key strength, making the model practical for widespread implementation.

The research team trained the model using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database and rigorously tested its performance on an independent dataset, the eICU Collaborative Research Database (eICU-CRD). This ‘training plus external validation’ approach strengthens the model’s reliability and generalizability across diverse patient populations and hospital settings.

XGBoost: The Algorithm of Choice

Among several machine learning algorithms evaluated – including logistic regression, random forests, and neural networks – XGBoost consistently outperformed the others in predicting mortality risk. Importantly, the researchers prioritized interpretability, utilizing SHapley Additive exPlanations (SHAP) to understand which clinical variables were driving the model’s predictions.

This interpretability is a significant departure from many “black box” AI models. By identifying key predictors like oxygenation indices, serum albumin levels, liver function indicators, and disease severity scores, the model provides clinicians with valuable insights into the factors influencing a patient’s prognosis.

Key Clinical Predictors Identified by the Model

The SHAP analysis revealed the critical role of several clinical factors in predicting 28-day mortality. These include:

  • Oxygenation Indices: Reflecting the patient’s ability to effectively exchange oxygen.
  • Serum Albumin Levels: Indicating nutritional status and overall health.
  • Liver Function Indicators: Signaling potential organ dysfunction.
  • Disease Severity Scores: Providing a comprehensive assessment of the patient’s illness.

This transparent framework allows clinicians to understand why the model is making a particular prediction, fostering trust and facilitating informed decision-making.

Future Trends: Integrating AI into Critical Care

This study represents a significant step towards integrating interpretable AI into routine clinical practice. The potential applications extend beyond simply predicting mortality risk.

Personalized Treatment Strategies

By identifying high-risk patients early, clinicians can tailor treatment strategies to individual needs. This could involve more aggressive interventions, closer monitoring, or proactive management of specific organ dysfunction.

Resource Allocation Optimization

In resource-constrained environments, the model can help prioritize care for patients at the highest risk of deterioration, ensuring that limited ICU beds and staff are allocated effectively.

Bedside and Web-Based Risk Assessment Tools

The research team envisions integrating the model into user-friendly tools accessible at the bedside or via web-based platforms, providing clinicians with real-time risk assessments.

Expanding the Scope of AI in Sepsis Management

This work builds on a growing body of research exploring the leverage of AI in sepsis management. Other areas of investigation include:

  • Early Sepsis Detection: Developing models to identify sepsis at its earliest stages, even before symptoms become apparent.
  • Antibiotic Stewardship: Optimizing antibiotic use to combat antimicrobial resistance.
  • Predictive Modeling for ARDS Development: Identifying patients at high risk of developing ARF, allowing for preventative measures.

FAQ

Q: What is sepsis-induced ARF?
A: Sepsis-induced acute respiratory failure (ARF) occurs when sepsis leads to a sudden and severe inability of the lungs to provide enough oxygen to the body.

Q: What is XGBoost?
A: XGBoost is a machine learning algorithm known for its accuracy and efficiency in handling complex datasets.

Q: How does SHAP analysis work?
A: SHAP (SHapley Additive exPlanations) is a method used to explain the output of machine learning models by quantifying the contribution of each feature to the prediction.

Q: Is this model ready for use in hospitals?
A: The model has been externally validated, but further implementation and integration into clinical workflows are needed before widespread adoption.

Did you grasp? Approximately 25-50% of sepsis patients develop acute respiratory distress syndrome (ARDS), significantly increasing their risk of mortality.

Pro Tip: Early identification of sepsis and ARF is critical. Clinicians should be vigilant for signs of these conditions and initiate prompt treatment.

This research marks a pivotal moment in the fight against sepsis. By harnessing the power of machine learning and prioritizing interpretability, we are moving closer to a future where AI empowers clinicians to deliver more precise, personalized, and effective care to the most vulnerable patients.

Explore further: Read more about the study on News Medical and learn about interpretable machine learning.

March 27, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

MSC Therapy: Reducing Severity of COVID-19 & Showing Promise for Sepsis Treatment

by Chief Editor March 20, 2026
written by Chief Editor

From Neonatal Care to Pandemic Breakthrough: Stem Cells Offer Hope for Inflammatory Diseases

Mesenchymal stem cells (MSCs), derived from the tissue of newborn babies’ umbilical cords, possess a remarkable ability: they can regulate the immune system. By releasing hormones like prostaglandins, MSCs influence the activity of T and B cells. This makes MSCs a potential therapeutic agent against severe inflammation, where the immune system overreacts.

Dresden’s Pioneering Research: A New Approach to Severe Illness

Researchers at the University Hospital Carl Gustav Carus Dresden, in collaboration with the Ottawa Health Research Institute, have demonstrated that MSC therapy can significantly improve outcomes in severe COVID-19 cases. Current studies are now exploring the potential of this therapy for patients battling severe sepsis.

The Dresden team, led by Mario Rüdiger, has spent over a decade working with MSCs. Marius Möbius and Daniel Freund developed a method to isolate these cells from donated umbilical cords. The cells are then purified, grown in nutrient-rich environments, combined with cells from other donations, and cryopreserved for future apply.

From Lung Disease in Infants to Combating COVID-19

Initially, the focus of this research was on treating remarkably premature babies, preventing chronic lung disease. However, the emergence of the COVID-19 pandemic in 2019 presented a new opportunity. Many patients succumbed to the virus due to an overactive immune response damaging lung tissue. The Dresden team, already collaborating with Canadian colleagues, recognized the potential of their therapy to address this critical issue.

Study Results: MSC Therapy Reduces Mortality and Improves Recovery

Published in the journal Stem Cell Reports, the study involved 37 patients with severe COVID-19. Researchers determined the appropriate dosage in the first 15 participants, followed by a randomized, double-blind study with 22 patients. Fourteen received the MSC therapy, while eight received a placebo. The results showed a significant reduction in mortality and improved recovery rates among those treated with MSCs.

The study was halted in May 2022 due to the widespread availability of vaccines and less virulent virus variants, limiting the number of eligible participants. Clinical trials have since resumed in 2024, focusing on patients with severe sepsis.

SaxoCell: Paving the Way for Routine MSC Treatment

The SaxoCell project, funded by the German federal government, aims to establish MSC therapy as a standard clinical practice. “If the data from the COVID study can be replicated in adults with severe sepsis, a therapy originally developed in neonatology could revolutionize treatment for adults,” says Mario Rüdiger.

Future Trends in MSC Therapy

The success in Dresden highlights a growing trend: the repurposing of therapies initially developed for specific conditions to address broader inflammatory challenges. MSC therapy isn’t limited to COVID-19 and sepsis; research is expanding into areas like autoimmune diseases, organ transplantation, and even neurodegenerative conditions.

Personalized MSC Therapy

One emerging trend is personalized MSC therapy. Instead of using “off-the-shelf” MSCs from donors, researchers are exploring the possibility of using a patient’s own MSCs, harvested and expanded in the lab. This approach could minimize the risk of immune rejection and potentially enhance therapeutic efficacy.

Combining MSCs with Other Therapies

Another area of investigation is combining MSC therapy with other treatments, such as immunomodulatory drugs or targeted therapies. This synergistic approach could amplify the therapeutic effect and address multiple aspects of the disease process.

Scaling Up Production and Reducing Costs

A significant challenge is scaling up the production of MSCs to meet clinical demand while reducing costs. Innovative bioreactor technologies and automated cell processing systems are being developed to address this issue.

FAQ

Q: What are mesenchymal stem cells?
A: Mesenchymal stem cells are cells that can develop into various types of cells, including bone, cartilage, and fat cells. They also have immunomodulatory properties.

Q: Where do these stem cells come from?
A: In this case, the stem cells are derived from umbilical cords donated after birth.

Q: Is MSC therapy widely available?
A: While MSC therapy is showing promise, We see not yet a routine treatment and is primarily available through clinical trials.

Q: What is the SaxoCell project?
A: SaxoCell is a German government-funded project aiming to make MSC therapy a standard clinical practice.

Did you recognize? Umbilical cord blood and tissue are rich sources of stem cells, often discarded after birth. Donating these tissues can contribute to life-saving research and therapies.

Pro Tip: Stay informed about clinical trials related to MSC therapy. Websites like clinicaltrials.gov provide information on ongoing studies worldwide.

Interested in learning more about regenerative medicine? Explore additional articles on our website or subscribe to our newsletter for the latest updates.

March 20, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Maternal antibodies protect newborns from severe E. coli infections, study finds

by Chief Editor March 11, 2026
written by Chief Editor

Maternal Antibodies: The Key to Protecting Newborns from Deadly E. Coli Infections

A groundbreaking study published March 11, 2026, in Nature reveals a critical link between maternal antibodies and protection against severe Escherichia coli (E. Coli) infections in newborns. Researchers at Cincinnati Children’s, collaborating with institutions across the US and Australia, have discovered that babies who develop severe E. Coli sepsis consistently exhibit lower levels of these crucial germ-fighting antibodies transferred from their mothers.

Why are Newborns Vulnerable?

Newborns are known to have immature immune systems, making them susceptible to infections. E. Coli, a common bacterium residing in the intestines of most people, is a leading cause of severe infection in newborns. Despite widespread exposure to E. Coli shortly after birth, severe infection occurs in only about one in every 1,000 live births. This disparity prompted researchers to investigate the protective factors at play.

The Role of Maternal Antibodies

The research team analyzed dried blood samples from 100 infants who developed E. Coli infection, comparing their antibody levels to those of uninfected infants. The analysis consistently showed reduced levels of antibodies targeting E. Coli in the infected babies. This suggests that a mother’s antibodies are a primary defense against this potentially life-threatening infection.

Probiotic Potential: Boosting Maternal Immunity

Researchers also explored potential preventative measures. Studies using mice demonstrated that introducing a probiotic strain of E. Coli, Nissle 1917, to mothers before pregnancy stimulated the production of protective antibodies. These antibodies effectively protected newborn mice against infection. This probiotic is currently available for human use in Europe, Asia, and Australia under the trade name Mutaflor.

“Understanding protection takes both types of evidence – what we can evaluate from specimens in human babies that naturally develop infection, and what we can test by experimentally causing infection,” explains Mark Schembri, PhD, co-author from the University of Queensland in Australia. “By strategically combining real-world human newborn screening samples with carefully designed infection models, we can start to pinpoint which antibody targets matter most and how broad protection might be achieved.”

Future Directions: Screening and Prevention

The findings pave the way for developing a screening test to identify newborns at high risk of severe E. Coli infection. Researchers also aim to develop a safe probiotic for mothers to strengthen their immunity and enhance antibody transfer to their babies. Susana Chavez-Bueno, MD, of Children’s Mercy Hospital in Kansas City, notes that neonatal sepsis can escalate rapidly, and clinicians require better tools for early risk identification and prevention.

The Promise of Personalized Maternal Immunity

This research highlights a growing trend in personalized medicine, specifically focusing on maternal immune optimization. Future advancements may involve:

  • Targeted Probiotic Therapies: Developing probiotic formulations specifically designed to stimulate the production of antibodies against prevalent neonatal pathogens.
  • Maternal Antibody Monitoring: Routine screening of pregnant women to assess their antibody levels against key pathogens, allowing for targeted interventions if deficiencies are identified.
  • Vaccine Development: Exploring the potential for vaccines that boost maternal antibody production, providing enhanced protection to newborns.

Did you know?

E. Coli is a highly adaptable bacterium, meaning it can change its surface proteins to evade the immune system. This makes it challenging to develop broadly effective antibodies, emphasizing the need for ongoing research and monitoring.

FAQ

Q: What is E. Coli sepsis?
A: E. Coli sepsis is a severe infection caused by the Escherichia coli bacterium, which can rapidly escalate and develop into life-threatening in newborns.

Q: How do mothers pass antibodies to their babies?
A: Mothers transfer antibodies to their babies primarily during pregnancy through the placenta.

Q: Is the Nissle 1917 probiotic available in the United States?
A: Currently, Nissle 1917 (Mutaflor) is not widely available in the United States, but research is ongoing to explore its potential benefits and regulatory approval.

Q: What can pregnant women do to boost their immunity?
A: Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and adequate sleep, can support a healthy immune system during pregnancy. Consult with your healthcare provider for personalized recommendations.

Pro Tip: Discuss your health history and any concerns about potential infections with your doctor during prenatal care. Early identification of risk factors can help ensure the best possible outcome for you and your baby.

Seek to learn more about newborn health and immunity? Explore our articles on infant vaccinations and postnatal care.

Share your thoughts! Have you experienced challenges with newborn health? Leave a comment below.

March 11, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Sepsis: Woman Survives Amputation After Dog Lick – Symptoms & France Stats

by Chief Editor February 24, 2026
written by Chief Editor

The Silent Threat of Sepsis: From Dog Licks to Quadruple Amputations – What the Future Holds

What begins as a seemingly minor ailment can rapidly escalate into a life-threatening crisis. This was the harrowing reality for Manjit Sangha, a 56-year-old British woman whose story serves as a stark warning about the dangers of sepsis. After 32 weeks in the hospital, including six cardiac arrests and a quadruple amputation, Sangha is finally home, but her ordeal highlights a growing concern: the often-overlooked threat of sepsis.

Understanding Sepsis: A Body Gone Haywire

Sepsis isn’t a disease itself, but rather a life-threatening response to an infection. The body’s immune system, instead of fighting off the infection, goes into overdrive, attacking its own tissues and organs. This can be triggered by bacterial, viral, fungal, or parasitic infections. A seemingly innocuous event, like a dog licking a small cut, can potentially initiate this cascade of events. The condition is particularly dangerous for individuals with weakened immune systems.

A Rising Public Health Crisis

The statistics are alarming. In France alone, sepsis is attributed to 57,000 deaths annually. Between 250,000 and 300,000 people are affected each year, with a hospital mortality rate of 25%, increasing to 50% in cases of septic shock. Experts predict a doubling of cases within the next 50 years, largely due to an aging population. Globally, sepsis was linked to 11 million deaths in 2017, yet remains largely unknown to the public.

The PETSEPSIS Study: Unveiling the Animal Connection

Recent research, including the PETSEPSIS multicentre retrospective observational cohort study conducted across 46 French ICUs between 2009 and 2019, is shedding light on the link between animal contact and sepsis. The study analyzed medical records of patients hospitalized for infections suspected of originating from cats and dogs. While the study focused on identifying characteristics and outcomes of ICU patients with sepsis transmitted by cats and dogs, it underscores the potential for zoonotic transmission of these dangerous infections.

Beyond Bites and Scratches: The Hidden Pathways

The case of Manjit Sangha illustrates that sepsis doesn’t always require a dramatic injury. A simple lick from a pet on a minor wound can be enough to introduce bacteria into the bloodstream. Bacteria like Pasteurella, Bartonella and Capnocytophaga are commonly found in the mouths of dogs and cats and can cause severe infections. The study referenced in the web search results identified these as potential sources of sepsis.

The Challenge of Antibiotic Resistance

Adding to the complexity, the World Health Organization warns that increasing antibiotic resistance can make treating sepsis even more difficult. As bacteria evolve to withstand common antibiotics, the window for effective intervention narrows, increasing the risk of severe complications and mortality.

Future Trends and Proactive Measures

Several trends are shaping the future of sepsis management:

  • Early Detection Technologies: Researchers are developing rapid diagnostic tools to identify sepsis in its early stages, before it progresses to septic shock. These tools may include biomarkers and advanced imaging techniques.
  • Personalized Medicine: Understanding individual risk factors and tailoring treatment plans based on a patient’s genetic profile and immune response could improve outcomes.
  • Enhanced Surveillance Systems: Strengthening surveillance systems to track sepsis cases and identify emerging hotspots will be crucial for public health preparedness.
  • Public Awareness Campaigns: Raising public awareness about the signs and symptoms of sepsis is essential for promoting early medical attention.
  • One Health Approach: Recognizing the interconnectedness of human, animal, and environmental health is vital for preventing zoonotic infections and reducing the risk of sepsis.

FAQ: Sepsis – Common Questions Answered

  • What are the early signs of sepsis? Fever, chills, rapid heart rate, rapid breathing, confusion, and extreme pain.
  • Is sepsis contagious? No, sepsis itself is not contagious. Yet, the infections that cause sepsis can be contagious.
  • Who is most at risk? Infants, young children, the elderly, and people with weakened immune systems or chronic illnesses.
  • What should I do if I suspect sepsis? Seek immediate medical attention. Time is critical.

Did you know? Sepsis can mimic the flu, making it difficult to diagnose in its early stages. Don’t dismiss persistent or worsening symptoms.

Pro Tip: If you have a wound, even a minor one, keep it clean and covered. If you notice signs of infection (redness, swelling, pus), see a doctor immediately.

The story of Manjit Sangha is a powerful reminder that sepsis is a serious threat that demands our attention. By understanding the risks, recognizing the symptoms, and advocating for early intervention, we can function towards a future where fewer lives are lost to this silent killer.

Learn More: Explore additional resources on sepsis prevention and treatment at the Pasteur Institute and the French Ministry of Health.

February 24, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Dog lick turns deadly! UK woman loses all four limbs to sepsis, warns it ‘can happen to anyone’

by Chief Editor February 22, 2026
written by Chief Editor

A Dog’s Affection, A Deadly Threat: The Rising Awareness of Sepsis from Animal Licks

A seemingly harmless lick from a beloved pet can, in rare cases, trigger a life-threatening cascade of events. This harrowing reality recently came to light with Manjit Sangha, a 56-year-old woman from Birmingham, England, who lost all four limbs after developing sepsis believed to have originated from a dog lick on a minor cut. Her story, while shocking, is prompting crucial conversations about sepsis awareness and the potential risks – however modest – associated with animal-borne bacteria.

The Rapid Onset of a Devastating Illness

In July 2025, Manjit Sangha’s condition deteriorated rapidly after initially feeling unwell following a day at work. Within 24 hours, she was found unconscious by her husband, Kam Sangha, with dangerously cold extremities and blue lips. Rushed to Fresh Cross Hospital, she was placed in a medically induced coma and endured six cardiac arrests during her 32-week hospital stay. Doctors determined she was suffering from sepsis, a condition where the body’s response to an infection spirals out of control, leading to organ dysfunction and potentially death.

Sepsis: A Silent Killer

Sepsis is a serious medical emergency affecting millions globally each year. The UK Sepsis Trust estimates around 50,000 sepsis-related deaths occur annually in the UK alone. It occurs when the immune system overreacts to an infection, attacking the body’s own tissues and organs. In Manjit’s case, doctors suspect bacteria from her dog’s saliva entered her bloodstream through a small cut or scratch.

Beyond Manjit: A Pattern of Concern

Manjit Sangha’s case isn’t isolated. An 83-year-old woman in Norfolk also tragically died last year after developing sepsis from a dog lick on a wound. In that instance, tests revealed the presence of pasteurella multocida, a bacterium commonly found in the mouths of animals. While severe outcomes are extremely rare, these cases highlight the potential for animal-borne bacteria to cause serious infections, particularly in individuals with compromised immune systems.

The Complications: Amputation and Recovery

To halt the spread of infection, surgeons were forced to amputate both of Manjit Sangha’s legs below the knee and both of her hands. Her spleen was also removed after she developed pneumonia and gallstones. Despite the immense physical and emotional toll, Manjit is determined to rebuild her life. She has expressed a strong desire to walk again and return to work, demonstrating remarkable resilience.

Raising Awareness and Funds

Manjit and her husband, Kam, have launched a GoFundMe campaign to raise funds for advanced prosthetics and to increase awareness about the dangers of sepsis. They have already raised over £30,842. Manjit has emphasized that sepsis “could happen to anybody” and urged people to take the condition seriously.

Understanding Disseminated Intravascular Coagulation (DIC)

Manjit’s case was further complicated by Disseminated Intravascular Coagulation (DIC), a rare and life-threatening condition causing abnormal blood clotting throughout the body. DIC can damage organs and significantly worsen the prognosis for sepsis patients.

What You Require to Recognize About Sepsis

Early recognition and treatment are critical for sepsis survival. Symptoms can include:

  • Slurred speech
  • Extreme shivering or muscle pain
  • Severe breathlessness
  • Skin that is mottled or discolored

Pro Tip: Trust Your Instincts

If you suspect sepsis, seek immediate medical attention. Don’t hesitate to call emergency services or proceed to the nearest hospital. Time is of the essence.

Frequently Asked Questions

Q: Is sepsis always caused by animal licks?
A: No. Sepsis can be caused by any type of infection, including bacterial, viral, or fungal infections. Animal licks are a very rare potential source.

Q: Who is most at risk of developing sepsis?
A: Individuals with weakened immune systems, chronic illnesses, open wounds, or recent surgeries are at higher risk.

Q: What is the treatment for sepsis?
A: Sepsis requires immediate medical intervention, typically involving antibiotics, intravenous fluids, and supportive care.

Q: Can sepsis be prevented?
A: While not always preventable, practicing good hygiene, promptly treating infections, and staying up-to-date on vaccinations can reduce the risk.

Q: What is the long-term outlook for sepsis survivors?
A: The long-term outlook varies depending on the severity of the sepsis and any resulting complications. Some survivors may experience lasting physical or cognitive impairments.

Learn more about sepsis from the UK Sepsis Trust.

Do you have a story about overcoming a health challenge? Share your experience in the comments below!

February 22, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Artificial lung keeps patient alive after lung removal

by Chief Editor February 5, 2026
written by Chief Editor

The Future of Artificial Lungs: Beyond Emergency Transplants

A recent breakthrough, detailed in the journal Med, showcases a novel total artificial lung (TAL) system successfully bridging a patient to transplant after a desperate bilateral pneumonectomy. This isn’t just a remarkable case study; it’s a glimpse into a future where artificial lungs move beyond emergency life support and become integral tools for diagnosing and treating severe lung disease.

From ECMO to Total Artificial Lungs: A Paradigm Shift

For decades, Extracorporeal Membrane Oxygenation (ECMO) has been the mainstay for supporting patients with Acute Respiratory Distress Syndrome (ARDS). ECMO provides temporary heart and lung support, but it doesn’t address the underlying lung damage. The mortality rate for ARDS patients with drug-resistant infections remains alarmingly high – over 80%. The challenge lies in determining if the lung injury is reversible. Traditional methods often fall short.

The TAL system represents a significant leap forward. Unlike ECMO, which primarily focuses on oxygenation, the TAL system, as demonstrated in the recent case, actively takes over both breathing and circulatory buffering. This is crucial because removing both lungs eliminates the natural buffering capacity of the pulmonary vasculature, potentially leading to right heart failure and blood clots. The flow-adaptive shunt in this new system dynamically adjusts to blood flow, preventing these complications.

Molecular Profiling: The Key to Identifying Irreversible Lung Damage

Perhaps the most exciting aspect of this case isn’t just the TAL system itself, but the accompanying molecular analysis. Researchers performed single-cell and spatial molecular profiling of the explanted lungs, revealing a landscape of irreversible damage – extensive fibrosis, immune cell dysfunction, and failed regeneration. This level of detail is transforming our understanding of ARDS.

“We’re moving beyond simply observing symptoms to understanding the fundamental molecular processes driving lung failure,” explains Dr. Emily Carter, a pulmonologist specializing in advanced lung therapies. “This allows us to potentially identify patients who will truly benefit from transplantation, avoiding unnecessary procedures and maximizing the chances of success.”

Did you know? Spatial transcriptomics, a technique used in this study, maps gene expression within the tissue, providing a detailed picture of how different cells interact and contribute to disease progression.

Beyond ARDS: Expanding Applications for Artificial Lung Technology

While the initial application focuses on bridging patients with severe ARDS to transplant, the potential of TAL technology extends far beyond. Consider these emerging areas:

  • Cystic Fibrosis: For patients with end-stage cystic fibrosis, a TAL system could provide support during lung transplantation or even as a long-term bridge to potential future therapies like gene editing.
  • Pulmonary Hypertension: Severe pulmonary hypertension can overwhelm the right side of the heart. A TAL system could offload the workload, allowing the heart to recover and potentially avoid transplantation.
  • Lung Cancer: In cases of locally advanced lung cancer requiring extensive resection, a TAL system could provide temporary support during and after surgery.
  • Influenza Pandemics: Future influenza pandemics, like the one that triggered the case study, could overwhelm healthcare systems. Portable and efficient TAL systems could become critical tools for managing severe cases.

The Role of Biomarkers and AI in Personalized Lung Support

The future of artificial lung technology isn’t just about hardware; it’s about integrating it with advanced diagnostics and artificial intelligence. Identifying biomarkers – measurable indicators of disease – that predict lung recovery is paramount. The molecular profiling techniques used in the recent case are paving the way for this.

AI algorithms can analyze vast datasets of patient data, including genomic information, imaging scans, and physiological parameters, to predict which patients will respond to a TAL system and optimize its settings for individual needs. This personalized approach will maximize efficacy and minimize complications.

Pro Tip: Researchers are actively exploring non-invasive biomarkers, such as circulating microRNAs, that could be used to assess lung injury severity and predict response to therapy.

Challenges and Future Directions

Despite the promise, significant challenges remain. TAL systems are complex and expensive. Long-term biocompatibility is a concern, as prolonged exposure to artificial materials can trigger inflammation and blood clots. Furthermore, widespread adoption requires rigorous clinical trials and standardized protocols.

Future research will focus on:

  • Developing more biocompatible materials for TAL components.
  • Miniaturizing TAL systems for increased portability and ease of use.
  • Integrating AI-powered control systems for personalized therapy.
  • Identifying novel biomarkers for early detection of irreversible lung damage.

FAQ: Artificial Lungs – What You Need to Know

  • What is the difference between ECMO and a TAL system? ECMO primarily provides oxygenation, while a TAL system takes over both breathing and circulatory support.
  • Is a TAL system a permanent solution? Currently, TAL systems are used as a bridge to transplant or recovery. Long-term use is still under investigation.
  • Who is a candidate for a TAL system? Patients with severe ARDS, particularly those with drug-resistant infections, are potential candidates.
  • How expensive is a TAL system? The cost is currently high, but researchers are working to reduce manufacturing costs and improve accessibility.

The successful use of a novel TAL system in a critically ill patient marks a turning point in the treatment of severe lung disease. As technology advances and our understanding of lung biology deepens, artificial lungs are poised to become an increasingly important tool for saving lives and improving the quality of life for patients with respiratory failure.

Want to learn more? Explore our articles on ARDS treatment options and the latest advancements in lung transplantation.

February 5, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Plex Expands Beyond Media Servers with New Social Features

    June 3, 2026
  • Czech Police Find Cocaine at Orthodox Priest’s Home; Church Transfers Him to Brazil

    June 3, 2026
  • Dragomir Mrsic’s Maverick Move Studio Hires Award-Winning Producer

    June 3, 2026
  • Crypto Mogul ‘The Godfather’ Pleads Guilty in $245M Bitcoin Kidnapping Plot

    June 3, 2026
  • Trump Labels Netanyahu ‘Crazy’ Amid Iran Peace Talks

    June 3, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World